Literature DB >> 10418132

Hemolysin of Aeromonas sobria stimulates production of cyclic AMP by cultured cells.

Y Fujii1, T Nomura, K Okamoto.   

Abstract

Hemolysin of Aeromonas sobria possesses both cytotoxic activity against mammalian cells and enterotoxic activity. Histopathological examination revealed that hemolysin causes diarrhea without damaging the intestinal epithelial cells. And the fluid accumulated in the mouse intestinal loop by the action of the hemolysin is watery. These observations indicated that the enterotoxic activity of hemolysin is not dependent on its cytotoxic activity. To clarify the mechanism of the enterotoxic action of hemolysin, we examined cyclic nucleotide levels in cultured cells exposed to this toxin. These results showed that hemolysin stimulates the production of cyclic AMP in cultured cells and the cyclic AMPs thus produced emerge in the milieu of cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10418132     DOI: 10.1111/j.1574-6968.1999.tb13643.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  3 in total

1.  Studies of the mechanism of action of the aerolysin-like hemolysin of Aeromonas sobria in stimulating T84 cells to produce cyclic AMP.

Authors:  Yoshio Fujii; Tomohiko Nomura; Ritsuko Yokoyama; Sumio Shinoda; Keinosuke Okamoto
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

2.  Aeromonas hydrophila beta-hemolysin induces active chloride secretion in colon epithelial cells (HT-29/B6).

Authors:  H J Epple; J Mankertz; R Ignatius; O Liesenfeld; M Fromm; M Zeitz; T Chakraborty; J D Schulzke
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

3.  Fluid secretion caused by aerolysin-like hemolysin of Aeromonas sobria in the intestines is due to stimulation of production of prostaglandin E2 via cyclooxygenase 2 by intestinal cells.

Authors:  Yoshio Fujii; Ken Tsurumi; Masaaki Sato; Eizo Takahashi; Keinosuke Okamoto
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.